维普中文期刊产品整合服务
10篇 您的检索式:作者名="Yogen"
    题名 作者 年代 出处 被引量
1Broadcast protocols in packet switched computer networks显示文摘Yogen dalal 1977Digital System Laboratory Deptartment of Electrical Engineering Stanford University1977,,:2
2Anti-N-methyl-D-aspartate receptor antibodies: A potentially treatable cause of encephalitis in the intensive care unit显示文摘Gerard Davies Sarosh R. Irani Cordelia Coltart Gordon Ingle Yogen Amin Christopher Taylor Jeremy Radcliffe Nicholas P. Hirsch Robin S. Howard Angela Vincent Dimitri M. Kullmann 2010Critical Care Medicine2010,,2:1
3Formation criterion for synthetic jets 显示文摘HOLMAN RYAN UTTURKAR YOGEN MITTAL RAJAT 2005AIAA Journal2005,43,10:1
4Reverse Path Forwarding of Broadcast Packets 显示文摘Dalal Yogen K Metcalfe Robert M 1978Communications of the ACM1978,21,12:1
5DNA hypomethylating agents and sickle cell disease显示文摘Yogen Sanntharmajah Donald Lavelle Joseph DeSimone British Journal of Haematology0,629,:1
6Reverse path forwarding of broadcast packets 显示文摘Yogen K Dalai Robert Metcaife 1978Communications of the ACM1978,21,12:1
7Molecular biology and pathogenicity of Mycoplasmas显示文摘RAZIN S YOGEN D NATO Y 1998Mic Mol Bio Rev1998,62,4:1
8A phase 2 trial of combination therapy with thalidomide, arsenic trioxide, dexamethasone, and ascorbic acid (TADA) in patients with overlap myelodysplastic/myeloproliferative neoplasms (MDS/MPN) or primary myelofibrosis (PMF)显示文摘Nelli Bejanyan Ramon V. Tiu Azra Raza Ania Jankowska Matt Kalaycio Anjali Advani Josephine Chan Yogen Saunthararajah Lindsey Mooney Jaroslaw P. Maciejewski Mikkael A. Sekeres 2011Cancer2011,,:1
9A phase 2 trial of combination therapy with thalidomide, arsenic trioxide, dexamethasone, and ascorbic acid (TADA) in patients with overlap myelodysplastic/myeloproliferative neoplasms (MDS/MPN) or primary myelofibrosis (PMF)显示文摘Nelli Bejanyan Ramon V. Tiu Azra Raza Ania Jankowska Matt Kalaycio Anjali Advani Josephine Chan Yogen Saunthararajah Lindsey Mooney Jaroslaw P. Maciejewski Mikkael A. Sekeres 2011Cancer2011,,16:1
10Successful use of very low dose subcutaneous decitabine to treat high-risk myelofibrosis with Sweet syndrome that was refractory to 5-azacitidine显示文摘Yang Liu Ali Tabarroki Steven Billings Valeria Visconte Heesun J. Rogers Edy Hasrouni Ricki Englehaupt Matt Kalaycio Mikkael A. Sekeres Yogen Saunthararajah Ramon V. Tiu 2014Leukemia & Lymphoma2014,,2:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费